Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose Venetoclax with Itraconazole + TACL in R/R ALL
NCT07039877Phase 2Recruiting
- Sponsor
- Hospital Universitario Dr. Jose E. Gonzalez
- Start
- Jan 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of venetoclax in acute lymphoblastic leukemia (ALL), sponsored by Hospital Universitario Dr. Jose E. Gonzalez. Started Jan 2025; status: recruiting.
02
Drugs
venetoclax
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT07039877.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07039877.